Hippocampal-sparing whole-brain radiotherapy: A "how-to" technique using helical tomotherapy and linear accelerator-based intensity-modulated radiotherapy

Vinai Gondi, Ranjini Tolakanahalli, Minesh P. Mehta, Dinesh Tewatia, Howard Rowley, John S. Kuo, Deepak Khuntia, Wolfgang A. Tome

Research output: Contribution to journalArticle

183 Citations (Scopus)

Abstract

Purpose: Sparing the hippocampus during cranial irradiation poses important technical challenges with respect to contouring and treatment planning. Herein we report our preliminary experience with whole-brain radiotherapy using hippocampal sparing for patients with brain metastases. Methods and Materials: Five anonymous patients previously treated with whole-brain radiotherapy with hippocampal sparing were reviewed. The hippocampus was contoured, and hippocampal avoidance regions were created using a 5-mm volumetric expansion around the hippocampus. Helical tomotherapy and linear accelerator (LINAC)-based intensity-modulated radiotherapy (IMRT) treatment plans were generated for a prescription dose of 30 Gy in 10 fractions. Results: On average, the hippocampal avoidance volume was 3.3 cm3, occupying 2.1% of the whole-brain planned target volume. Helical tomotherapy spared the hippocampus, with a median dose of 5.5 Gy and maximum dose of 12.8 Gy. LINAC-based IMRT spared the hippocampus, with a median dose of 7.8 Gy and maximum dose of 15.3 Gy. On a per-fraction basis, mean dose to the hippocampus (normalized to 2-Gy fractions) was reduced by 87% to 0.49 Gy2 using helical tomotherapy and by 81% to 0.73 Gy2 using LINAC-based IMRT. Target coverage and homogeneity was acceptable with both IMRT modalities, with differences largely attributed to more rapid dose fall-off with helical tomotherapy. Conclusion: Modern IMRT techniques allow for sparing of the hippocampus with acceptable target coverage and homogeneity. Based on compelling preclinical evidence, a Phase II cooperative group trial has been developed to test the postulated neurocognitive benefit.

Original languageEnglish (US)
Pages (from-to)1244-1252
Number of pages9
JournalInternational Journal of Radiation Oncology Biology Physics
Volume78
Issue number4
DOIs
StatePublished - Nov 4 2010
Externally publishedYes

Fingerprint

hippocampus
Intensity-Modulated Radiotherapy
Particle Accelerators
linear accelerators
brain
radiation therapy
accelerators
Radiotherapy
Hippocampus
dosage
Brain
avoidance
homogeneity
metastasis
Cranial Irradiation
planning
Prescriptions
irradiation
expansion
Neoplasm Metastasis

Keywords

  • Helical tomotherapy
  • hippocampal avoidance
  • neurocognitive function
  • Radiation Therapy Oncology Group (RTOG) 0933
  • whole-brain radiotherapy

ASJC Scopus subject areas

  • Oncology
  • Radiology Nuclear Medicine and imaging
  • Radiation
  • Cancer Research
  • Medicine(all)

Cite this

Hippocampal-sparing whole-brain radiotherapy : A "how-to" technique using helical tomotherapy and linear accelerator-based intensity-modulated radiotherapy. / Gondi, Vinai; Tolakanahalli, Ranjini; Mehta, Minesh P.; Tewatia, Dinesh; Rowley, Howard; Kuo, John S.; Khuntia, Deepak; Tome, Wolfgang A.

In: International Journal of Radiation Oncology Biology Physics, Vol. 78, No. 4, 04.11.2010, p. 1244-1252.

Research output: Contribution to journalArticle

Gondi, Vinai ; Tolakanahalli, Ranjini ; Mehta, Minesh P. ; Tewatia, Dinesh ; Rowley, Howard ; Kuo, John S. ; Khuntia, Deepak ; Tome, Wolfgang A. / Hippocampal-sparing whole-brain radiotherapy : A "how-to" technique using helical tomotherapy and linear accelerator-based intensity-modulated radiotherapy. In: International Journal of Radiation Oncology Biology Physics. 2010 ; Vol. 78, No. 4. pp. 1244-1252.
@article{32e6f2e2a25f4df29d249db6fd641f5b,
title = "Hippocampal-sparing whole-brain radiotherapy: A {"}how-to{"} technique using helical tomotherapy and linear accelerator-based intensity-modulated radiotherapy",
abstract = "Purpose: Sparing the hippocampus during cranial irradiation poses important technical challenges with respect to contouring and treatment planning. Herein we report our preliminary experience with whole-brain radiotherapy using hippocampal sparing for patients with brain metastases. Methods and Materials: Five anonymous patients previously treated with whole-brain radiotherapy with hippocampal sparing were reviewed. The hippocampus was contoured, and hippocampal avoidance regions were created using a 5-mm volumetric expansion around the hippocampus. Helical tomotherapy and linear accelerator (LINAC)-based intensity-modulated radiotherapy (IMRT) treatment plans were generated for a prescription dose of 30 Gy in 10 fractions. Results: On average, the hippocampal avoidance volume was 3.3 cm3, occupying 2.1{\%} of the whole-brain planned target volume. Helical tomotherapy spared the hippocampus, with a median dose of 5.5 Gy and maximum dose of 12.8 Gy. LINAC-based IMRT spared the hippocampus, with a median dose of 7.8 Gy and maximum dose of 15.3 Gy. On a per-fraction basis, mean dose to the hippocampus (normalized to 2-Gy fractions) was reduced by 87{\%} to 0.49 Gy2 using helical tomotherapy and by 81{\%} to 0.73 Gy2 using LINAC-based IMRT. Target coverage and homogeneity was acceptable with both IMRT modalities, with differences largely attributed to more rapid dose fall-off with helical tomotherapy. Conclusion: Modern IMRT techniques allow for sparing of the hippocampus with acceptable target coverage and homogeneity. Based on compelling preclinical evidence, a Phase II cooperative group trial has been developed to test the postulated neurocognitive benefit.",
keywords = "Helical tomotherapy, hippocampal avoidance, neurocognitive function, Radiation Therapy Oncology Group (RTOG) 0933, whole-brain radiotherapy",
author = "Vinai Gondi and Ranjini Tolakanahalli and Mehta, {Minesh P.} and Dinesh Tewatia and Howard Rowley and Kuo, {John S.} and Deepak Khuntia and Tome, {Wolfgang A.}",
year = "2010",
month = "11",
day = "4",
doi = "10.1016/j.ijrobp.2010.01.039",
language = "English (US)",
volume = "78",
pages = "1244--1252",
journal = "International Journal of Radiation Oncology Biology Physics",
issn = "0360-3016",
publisher = "Elsevier Inc.",
number = "4",

}

TY - JOUR

T1 - Hippocampal-sparing whole-brain radiotherapy

T2 - A "how-to" technique using helical tomotherapy and linear accelerator-based intensity-modulated radiotherapy

AU - Gondi, Vinai

AU - Tolakanahalli, Ranjini

AU - Mehta, Minesh P.

AU - Tewatia, Dinesh

AU - Rowley, Howard

AU - Kuo, John S.

AU - Khuntia, Deepak

AU - Tome, Wolfgang A.

PY - 2010/11/4

Y1 - 2010/11/4

N2 - Purpose: Sparing the hippocampus during cranial irradiation poses important technical challenges with respect to contouring and treatment planning. Herein we report our preliminary experience with whole-brain radiotherapy using hippocampal sparing for patients with brain metastases. Methods and Materials: Five anonymous patients previously treated with whole-brain radiotherapy with hippocampal sparing were reviewed. The hippocampus was contoured, and hippocampal avoidance regions were created using a 5-mm volumetric expansion around the hippocampus. Helical tomotherapy and linear accelerator (LINAC)-based intensity-modulated radiotherapy (IMRT) treatment plans were generated for a prescription dose of 30 Gy in 10 fractions. Results: On average, the hippocampal avoidance volume was 3.3 cm3, occupying 2.1% of the whole-brain planned target volume. Helical tomotherapy spared the hippocampus, with a median dose of 5.5 Gy and maximum dose of 12.8 Gy. LINAC-based IMRT spared the hippocampus, with a median dose of 7.8 Gy and maximum dose of 15.3 Gy. On a per-fraction basis, mean dose to the hippocampus (normalized to 2-Gy fractions) was reduced by 87% to 0.49 Gy2 using helical tomotherapy and by 81% to 0.73 Gy2 using LINAC-based IMRT. Target coverage and homogeneity was acceptable with both IMRT modalities, with differences largely attributed to more rapid dose fall-off with helical tomotherapy. Conclusion: Modern IMRT techniques allow for sparing of the hippocampus with acceptable target coverage and homogeneity. Based on compelling preclinical evidence, a Phase II cooperative group trial has been developed to test the postulated neurocognitive benefit.

AB - Purpose: Sparing the hippocampus during cranial irradiation poses important technical challenges with respect to contouring and treatment planning. Herein we report our preliminary experience with whole-brain radiotherapy using hippocampal sparing for patients with brain metastases. Methods and Materials: Five anonymous patients previously treated with whole-brain radiotherapy with hippocampal sparing were reviewed. The hippocampus was contoured, and hippocampal avoidance regions were created using a 5-mm volumetric expansion around the hippocampus. Helical tomotherapy and linear accelerator (LINAC)-based intensity-modulated radiotherapy (IMRT) treatment plans were generated for a prescription dose of 30 Gy in 10 fractions. Results: On average, the hippocampal avoidance volume was 3.3 cm3, occupying 2.1% of the whole-brain planned target volume. Helical tomotherapy spared the hippocampus, with a median dose of 5.5 Gy and maximum dose of 12.8 Gy. LINAC-based IMRT spared the hippocampus, with a median dose of 7.8 Gy and maximum dose of 15.3 Gy. On a per-fraction basis, mean dose to the hippocampus (normalized to 2-Gy fractions) was reduced by 87% to 0.49 Gy2 using helical tomotherapy and by 81% to 0.73 Gy2 using LINAC-based IMRT. Target coverage and homogeneity was acceptable with both IMRT modalities, with differences largely attributed to more rapid dose fall-off with helical tomotherapy. Conclusion: Modern IMRT techniques allow for sparing of the hippocampus with acceptable target coverage and homogeneity. Based on compelling preclinical evidence, a Phase II cooperative group trial has been developed to test the postulated neurocognitive benefit.

KW - Helical tomotherapy

KW - hippocampal avoidance

KW - neurocognitive function

KW - Radiation Therapy Oncology Group (RTOG) 0933

KW - whole-brain radiotherapy

UR - http://www.scopus.com/inward/record.url?scp=77958472320&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77958472320&partnerID=8YFLogxK

U2 - 10.1016/j.ijrobp.2010.01.039

DO - 10.1016/j.ijrobp.2010.01.039

M3 - Article

C2 - 20598457

AN - SCOPUS:77958472320

VL - 78

SP - 1244

EP - 1252

JO - International Journal of Radiation Oncology Biology Physics

JF - International Journal of Radiation Oncology Biology Physics

SN - 0360-3016

IS - 4

ER -